TY - JOUR
T1 - A novel germ line p53 mutation in intron 6 in diverse childhood malignancies
AU - Avigad, Smadar
AU - Barel, Dalit
AU - Blau, Orit
AU - Malka, Ayelet
AU - Zoldan, Meira
AU - Mor, Celia
AU - Fogel, Mina
AU - Cohen, Ian J.
AU - Stark, B.
AU - Goshen, Y.
AU - Stein, J.
AU - Zaizov, Rina
N1 - Funding Information:
We thank Prof V Rotter for our stimulating discussions, and Ilana Gelernter for the statistical analysis. This work is in partial fulfillment of the requirements for the Ph.D. degree of Dalit Barel and Orit Blau from the Sackler School of Medicine at Tel Aviv University. This work was supported in part by the Israel Cancer Association, Chief Scientist, Israel Ministry of Health 2505, Israel Lottery Foundation in the Memory of Pinhas Sapir, the Gilad Fund and the Josefina Maus and Gabriela Cesarman Maus Chair for Pediatric Hematology Oncology.
PY - 1997
Y1 - 1997
N2 - Screening for p53 mutations in exons 5 to 8 in 124 pediatric malignancies identified 18 abnormal shifts using single strand conformation polymorphism: 12 were missense mutations and in 6, no mutation was detected in the exon or in the splice donor acceptor sequences. Sequencing was then performed in the adjacent introns, revealing a G to A base substitution at 39 base pairs upstream to exon 7. This mutation was identified in the germ line of five of the patients, and also in the father of one, whose parents were available. For comparison, of the 184 normal controls similarly screened, only one had this mutation (P = 0.036). Positive staining of p53 protein was observed in three of the paraffin embedded tissues that were available: brain tumor, rhabdomyosarcoma, and lymphocytes from a normal lymph node from the rhabdomyosarcoma patient. All tumors with the identified intron mutation were Li-Fraumeni syndrome tumors. Sequencing of all exons including splice sites was performed and revealed no mutation. We suggest that this mutation in intron 6 of the p53 gene stabilizes the wild type p53 protein, resulting in its abnormal accumulation. Mutations in the noncoding region of p53 should be further studied.
AB - Screening for p53 mutations in exons 5 to 8 in 124 pediatric malignancies identified 18 abnormal shifts using single strand conformation polymorphism: 12 were missense mutations and in 6, no mutation was detected in the exon or in the splice donor acceptor sequences. Sequencing was then performed in the adjacent introns, revealing a G to A base substitution at 39 base pairs upstream to exon 7. This mutation was identified in the germ line of five of the patients, and also in the father of one, whose parents were available. For comparison, of the 184 normal controls similarly screened, only one had this mutation (P = 0.036). Positive staining of p53 protein was observed in three of the paraffin embedded tissues that were available: brain tumor, rhabdomyosarcoma, and lymphocytes from a normal lymph node from the rhabdomyosarcoma patient. All tumors with the identified intron mutation were Li-Fraumeni syndrome tumors. Sequencing of all exons including splice sites was performed and revealed no mutation. We suggest that this mutation in intron 6 of the p53 gene stabilizes the wild type p53 protein, resulting in its abnormal accumulation. Mutations in the noncoding region of p53 should be further studied.
KW - Childhood malignancies
KW - Germ line mutation
KW - Intron
KW - P53
UR - http://www.scopus.com/inward/record.url?scp=8244238392&partnerID=8YFLogxK
U2 - 10.1038/sj.onc.1200990
DO - 10.1038/sj.onc.1200990
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:8244238392
SN - 0950-9232
VL - 14
SP - 1541
EP - 1545
JO - Oncogene
JF - Oncogene
IS - 13
ER -